Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
about
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with establishedMonogenic dyslipidemias: window on determinants of plasma lipoprotein metabolismHepatic lipase is localized at the parenchymal cell microvilli in rat liverComparative analyses of lipoprotein lipase, hepatic lipase, and endothelial lipase, and their binding properties with known inhibitors.Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population.Decreases in the serum VLDL-TG/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels.Expression of human hepatic lipase negatively impacts apolipoprotein A-I production in primary hepatocytes from Lipc-null mice.Mechanisms of lipase maturation.Genetic causes of high and low serum HDL-cholesterol.Gene therapy for dyslipidemia: clinical prospects.High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.No prescription for despair.Hepatic lipase deficiency.Endothelial lipase: direct evidence for a role in HDL metabolism.Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport.Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet.Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes.Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy responseOverexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins.Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism.Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic miceReverse cholesterol transport and cholesterol efflux in atherosclerosis.Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species.Human genetics of variation in high-density lipoprotein cholesterol.Biochemistry and pathophysiology of intravascular and intracellular lipolysis.A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasmaThe independent relationship between triglycerides and coronary heart disease.Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endotheliumAssociation of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.Hyperlipoproteinemia type 3: the forgotten phenotype.HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.Insulin and lipoprotein metabolism with special reference to the diabetic state.Fatty acids liberated from high-density lipoprotein phospholipids by endothelial-derived lipase are incorporated into lipids in HepG2 cells.Human hepatic lipase subunit structure determination.Gene therapy for atherosclerosis.
P2860
Q24802147-6D6AF2EC-7047-4725-9EDB-1F569F19C845Q28363810-02DAFB1A-F7D1-44CE-972B-708677089FC3Q28581153-7C7B454C-7439-4C3C-9A97-40C0444709F5Q31132390-3F6C6EED-2202-4B82-B11A-497CA7D4B07FQ33577888-A1CB1051-38D3-4B22-82C0-14D250826F2FQ33833805-B132AEFD-3702-4F21-9FD6-58114F05A3EDQ33858537-0751A0C9-7C5F-4256-8C2E-45C05C453E78Q33904125-323D1AA2-C6EC-4433-8AAE-72C65BC51CDEQ33993060-958B5E48-3B29-4A3E-896D-1910CD7450D7Q34107177-D3E83CEC-597A-4AA3-B4EC-5D0FA36B3905Q34107511-14471985-E86F-4F13-A03B-EBAC102ED563Q34155049-F5D0DF4C-62F8-49E7-ACA8-E928AF6F6C14Q34651427-7131F73E-09FE-4191-9AD5-B8DBA1AE2C6CQ34707630-3EF738A7-5E6B-45ED-8126-EC3B71038893Q34756336-C0DC8E9E-3885-4ABA-A416-43F8DD0336A7Q34830395-2A38203E-7C5C-453C-87C2-97C9A4A55286Q34901554-77E4F8DF-149C-4471-91C8-BCB65C7434B4Q35086127-941DFB94-6FDB-4FA8-BB5B-8554EAD05110Q35249345-84E51199-4E9C-4A40-8609-5A46B6B35500Q35576667-5D9F3275-0CB2-4EE4-9EF9-1D36A93EB8DDQ35743918-116BBE72-A66A-4361-B5DA-309AA6DBEF11Q35784094-0B4EC7B2-1306-4D4D-9BB0-EE3661D59636Q35824568-A14B4822-5FA2-4E25-86A5-D351C2F7CB8AQ35824669-157EB32A-CAE8-431D-A30E-FCC0741EDFF1Q36300834-4EF25128-6AF3-4DF1-A115-FD5C7ECD000BQ36493893-7089E449-0521-4256-9316-5B02306A7165Q36503521-74569699-8753-4D37-A1E8-7591D6C66658Q36708030-B85B3D75-CA23-44D4-9720-6FAE3AFDAAB7Q36727383-A7B7FFCC-6555-4D48-800A-C0B6E59E60A5Q37167521-2D9BC3E2-0BCE-46C1-A65A-9C68E711CF58Q37351772-01A258CB-7BFC-4763-B6D7-9DC7B571ADFCQ37378483-2E45EA57-CDF7-4B24-ACD5-DEB29EFE39B5Q38235600-6EC45409-F018-42CD-A565-7023EABBF4AEQ38630971-F912F277-A4CE-494A-B344-1A9019C4080CQ39442094-D72302B1-3A3A-456F-A7C9-FD0F0A63FED0Q39614897-47C9BAC1-0100-4027-8060-1C938110A269Q40579349-AA784497-FA94-41F0-9E34-399686C3E8D9Q40674487-A3FDE0B2-351A-4885-9FF2-D38A11DEE3B1Q41168114-0F2C28CA-0F47-4B31-803C-E0D933C43085Q41465066-1682D66B-C7EB-4D53-8B81-4C54731E4B88
P2860
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
description
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1993
@ast
scientific journal article
@en
vedecký článok (publikovaný 1993/05/01)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/05/01)
@nl
наукова стаття, опублікована в травні 1993
@uk
مقالة علمية (نشرت في مايو 1993)
@ar
name
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@ast
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@en
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@nl
type
label
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@ast
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@en
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@nl
prefLabel
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@ast
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@en
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@nl
P2093
P356
P1476
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
@en
P2093
D J Jenkins
G F Maguire
J A Little
R A Hegele
T S Wolever
P304
P356
10.1161/01.ATV.13.5.720
P577
1993-05-01T00:00:00Z